Autonomic Therapy Initiative (ATI)

About BIOS Health

BIOS Health is developing a foundational neural interface and AI platform to translate neural signals into targeted digital therapeutics, starting with cardiovascular disease. The company's core technology enables real-time reading and writing of neural data to correct faulty organ signals, positioning it at the forefront of bioelectronic medicine. With a strong scientific advisory board and operations in Cambridge and Montreal, BIOS is advancing its Autonomic Therapy Initiative and Neural Dosing Platform through partnerships and internal R&D. The long-term vision is to establish a new infrastructure for neural digital therapies across multiple chronic conditions.

Therapeutic Areas

Other Cardiovascular Diseases Drugs